Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.192 EUR | +0.68% |
|
-7.45% | -7.45% |
06-14 | Abionyx: positive response from FDA, share price rises | CF |
06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.45% | 40.81M | |
+16.57% | 122B | |
+21.60% | 116B | |
+22.18% | 27.03B | |
-21.32% | 20.36B | |
-16.89% | 16.43B | |
-17.97% | 15.91B | |
-44.74% | 15.6B | |
+61.97% | 14.94B | |
+3.50% | 13.59B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeteutics Holding will Change its Name to ABIONYX Pharma SA